GP Pharm

GP Pharm S.A. is an active Spanish biopharmaceutical company specializing in the research, development, manufacturing, and marketing of injectable peptide-based pharmaceuticals with a focus on urology and oncology. The company utilizes advanced microencapsulation technologies such as liposomes and lipid nanoparticles to enhance drug delivery. It offers both proprietary products—such as Cetrorelix Acetate—and contract manufacturing services for third parties. Its pipeline includes commercialized APIs/excipients/intermediates with ongoing R&D activities targeting parenteral therapies primarily within its core therapeutic areas.